Evidence map›Paper›PMID 20425255›Full record

ReviewCurrent atherosclerosis reports2010

Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.

Alan Daugherty, Aruna Poduri, Xiaofeng Chen, Hong Lu, Lisa A Cassis

Open access · hybridAbstract readReview
In one paragraph

Review in Current atherosclerosis reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Lipotoxicity-Related Hematological Disorders in Obesity.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. Article
  5. The roles of FGF21 in atherosclerosis pathogenesis.Reviews in endocrine & metabolic disorders · 2019
    Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alan DaughertySaha Cardiovascular Research Center, University of Kentucky, BBSRB, Room B-243, Lexington, KY 40536-0509, USA. Alan.Daugherty@uky.edu
Aruna Poduri
Xiaofeng Chen
Hong Lu
Lisa A Cassis
University of Kentucky · US

Funding

Sources and effects of angiotensin peptides in atherosclerosisR01HL062846 · NHLBI · UNIVERSITY OF KENTUCKY · PI DAUGHERTY, ALAN · 2000 to 2012
$2.8M
NHLBI NIH HHS HL62846NHLBI NIH HHS R01 HL062846
6 · The paper itself

Abstract

The renin angiotensin system (RAS) has profound effects on atherosclerosis development in animal models, which is partially complimented by evidence in the human disease. Although angiotensin II was considered to be the principal effector of the RAS, a broader array of bioactive angiotensin peptides have been identified that have increased the scope of enzymes and receptors in the RAS. Genetic interruption of the synthesis of these peptides has not been extensively performed in experimental or human studies. A few studies demonstrate that interruption of a component of the angiotensin peptide synthesis pathway reduces experimental lesion formation. The evidence in human studies has not been consistent. Conversely, genetic manipulation of the RAS receptors has demonstrated that AT1a receptors are profoundly involved in experimental atherosclerosis. Few studies have reported links of genetic variants of angiotensin II receptors to human atherosclerotic diseases. Further genetic studies are needed to define the role of RAS in atherosclerosis.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationAngiotensinsAnimalsAtherosclerosisDisease Models, AnimalHumansPrognosisReceptors, AngiotensinRenin-Angiotensin SystemAngiotensinsReceptors, Angiotensin

Identifiers

PMID20425255
PMCPMC2857789
OpenAlexW1997331212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.